Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Short term Debt (2021 - 2022)

Historic Short term Debt for ADC Therapeutics (ADCT) over the last 2 years, with Q4 2022 value amounting to $12.5 million.

  • ADC Therapeutics' Short term Debt rose 8971.86% to $12.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $12.5 million, marking a year-over-year increase of 8971.86%. This contributed to the annual value of $12.5 million for FY2022, which is 8971.86% up from last year.
  • Per ADC Therapeutics' latest filing, its Short term Debt stood at $12.5 million for Q4 2022, which was up 8971.86% from $6.6 million recorded in Q4 2021.
  • Over the past 5 years, ADC Therapeutics' Short term Debt peaked at $12.5 million during Q4 2022, and registered a low of $6.6 million during Q4 2021.